Drug:
Reaction: DYSPNOEA
20250101 - 20251231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 25138820 |
US |
1 | |
Asthma, Wheezing, Dyspnoea, Fatigue, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 2 | 25138939 |
HR |
61 | 1 |
Pyrexia, COVID-19, Confusional state, Dyspnoea, Dysgraphia, Hypogammaglobulinaemia, Respiratory failure, |
||||
GLOFITAMAB, OBINUTUZUMAB, |
||||
| 3 | 25139011 |
US |
||
Troponin increased, Red blood cell count decreased, Cardiac discomfort, Vomiting, Dyspnoea, |
||||
ACALABRUTINIB, ALBUTEROL SULFATE, ALBUTEROL, TADALAFIL, FINASTERIDE, HYDROXYZINE, INSULIN GLARGINE, LEVOTHYROXINE, INSULIN ASPART, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, SOLIFENACIN SUCCINATE, SILDENAFIL CITRATE, ZOLPIDEM TARTRATE, |
||||
| 4 | 25139014 |
DE |
70 | 2 |
Metal poisoning, Inflammation, Dyspnoea, Mineral metabolism disorder, Swelling, Eating disorder, Blood pressure increased, Muscle atrophy, Scoliosis, Musculoskeletal stiffness, Sleep disorder, Muscle spasms, Pain, Chills, Pyrexia, Drug intolerance, |
||||
IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, DUPILUMAB, CALCIUM, MAGNESIUM, |
||||
| 5 | 25139123 |
IT |
19 | 2 |
Dyspnoea, Nausea, Vomiting, |
||||
SERTRALINE, SERTRALINE, LITHIUM CARBONATE, |
||||
| 6 | 25139221 |
MY |
70 | 2 |
Neutropenic sepsis, Tachycardia, Hypotension, Pleural effusion, Dyspnoea, |
||||
CARBOPLATIN, |
||||
| 7 | 25139223 |
TR |
63 | 2 |
Dyspnoea, Tachycardia, Skin discolouration, Oxygen saturation decreased, |
||||
PERTUZUMAB, |
||||
| 8 | 25139288 |
US |
63 | 2 |
Urticaria, Tachycardia, Dyspnoea, Swollen tongue, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 9 | 25139409 |
US |
||
Localised infection, Product dose omission issue, Dyspnoea, |
||||
DAPAGLIFLOZIN, |
||||
| 10 | 25139437 |
MY |
72 | 2 |
Neutropenic sepsis, Dyspnoea, Pyrexia, Cough, Rhinorrhoea, Neutrophil count decreased, |
||||
CARBOPLATIN, |
||||
| 11 | 25139524 |
CA |
29 | |
Altered state of consciousness, Flashback, Hyperhidrosis, Dyspnoea, Panic attack, |
||||
BUPROPION HYDROCHLORIDE, |
||||
| 12 | 25139533 |
CA |
||
Glomerular filtration rate decreased, Blood urea increased, Blood creatine increased, Renal impairment, Peripheral swelling, Dyspnoea, Renal disorder, Asthma, |
||||
ALBUTEROL SULFATE, FUROSEMIDE, |
||||
| 13 | 25139536 |
US |
79 | 2 |
Dyspnoea, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 14 | 25139565 |
US |
80 | 1 |
Asthenia, Dyspnoea, |
||||
LENALIDOMIDE, |
||||
| 15 | 25139681 |
US |
||
Dyspnoea, Wrong technique in product usage process, |
||||
ALBUTEROL SULFATE, |
||||
| 16 | 25139683 |
US |
||
Coronary artery disease, Bronchial wall thickening, Pulmonary mass, Bronchomalacia, Pulmonary oedema, Cough, Dyspnoea, Wheezing, Hilar lymphadenopathy, Escherichia infection, Weight decreased, Environmental exposure, |
||||
ALBUTEROL SULFATE, ALBUTEROL, TICAGRELOR, MOMETASONE, SEMAGLUTIDE, GENTAMICIN, GENTAMICIN SULFATE, |
||||
| 17 | 25139830 |
CA |
65 | 2 |
Asthma, Drug hypersensitivity, Dyspnoea, Oedema, Pneumonia, Vomiting, Wheezing, |
||||
OMALIZUMAB, OMALIZUMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, CLONAZEPAM, CLONAZEPAM, |
||||
| 18 | 25139953 |
US |
21 | 2 |
Dyspnoea, Maternal exposure during pregnancy, Uterine dilation and curettage, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 19 | 25139986 |
CA |
47 | 2 |
Cyanosis, Dyspnoea, Fatigue, Hypoaesthesia, Muscular weakness, Sensory loss, Dizziness, Myalgia, Oedema, |
||||
DUPILUMAB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, DEXLANSOPRAZOLE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, LEVOTHYROXINE SODIUM, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 20 | 25140021 |
JP |
51 | 1 |
Cardiac arrest, Hypersensitivity, Chills, Dyspnoea, |
||||
| 21 | 25140065 |
IT |
19 | 2 |
Dyspnoea, Nausea, Vomiting, Intentional product misuse, Intentional overdose, |
||||
SERTRALINE, SERTRALINE, SERTRALINE, SERTRALINE, SERTRALINE, SERTRALINE, SERTRALINE, SERTRALINE, LITHIUM CARBONATE, LITHIUM CARBONATE, LITHIUM CARBONATE, LITHIUM CARBONATE, |
||||
| 22 | 25140076 |
US |
62 | 2 |
Intervertebral disc operation, Upper respiratory tract infection, Dyspnoea, Pain, Wheezing, Cough, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
| 23 | 25140158 |
US |
87 | |
Asthma, Pulmonary hypertension, Meningitis aseptic, Chronic lymphocytic leukaemia, COVID-19, Cardiac failure, Confusional state, Adrenal insufficiency, Oxygen saturation abnormal, Dyspnoea, Lymphoedema, Diastolic dysfunction, Hypersensitivity, Snoring, Insomnia, Dyspnoea exertional, Upper-airway cough syndrome, Productive cough, Cough, Wheezing, Fatigue, Nasopharyngitis, Leukocytosis, Lymphocytosis, Pulmonary mass, Oesophageal disorder, Chest discomfort, Device malfunction, Poor quality sleep, Somnolence, Device use issue, Illness, Hypertension, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, MONTELUKAST, FLUTICASONE PROPIONATE, TRIPROLIDINE HCL, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, OBINUTUZUMAB, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, FUROSEMIDE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, AZELASTINE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, CARVEDILOL, VALACYCLOVIR HYDROCHLORIDE, ERGOCALCIFEROL, METHYLPREDNISOLONE SODIUM SUCCINATE, |
||||
| 24 | 25140514 |
US |
1 | |
Pneumonitis, Tachycardia, Dyspnoea, |
||||
ENSIFENTRINE, VITAMIN C, NAPROXEN SODIUM, NAPROXEN SODIUM TABLET, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, MONTELUKAST, |
||||
| 25 | 25140539 |
CN |
74 | |
Interstitial lung disease, Dyspnoea, Pyrexia, Interstitial lung disease, Acute respiratory distress syndrome, Pneumonitis, Condition aggravated, |
||||
OSIMERTINIB, |
||||
| 26 | 25140557 |
PL |
63 | 1 |
Multiple organ dysfunction syndrome, Hypotonia, Cardiac arrest, Anaphylactic reaction, Dyspnoea, Oedema mucosal, Vomiting, Nausea, Erythema, |
||||
IOHEXOL, IOHEXOL, |
||||
| 27 | 25140561 |
US |
47 | 2 |
Hypoxia, Obstructive airways disorder, Dyspnoea, Asthma, |
||||
DUPILUMAB, DUPILUMAB, FAMOTIDINE, |
||||
| 28 | 25140697 |
TW |
70 | 1 |
Syncope, Cyanosis, Dyspnoea, Pallor, Altered state of consciousness, Unresponsive to stimuli, Pulseless electrical activity, Cardiac arrest, Ventricular fibrillation, |
||||
PACLITAXEL, PACLITAXEL, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, CISPLATIN, CISPLATIN, |
||||
| 29 | 25140698 |
US |
53 | 2 |
Angioedema, Dyspnoea, Heart rate decreased, Hypoxia, |
||||
FERRIC MALTOL, PROGESTERONE, CALCIUM, QUERCETIN, QUERCETIN,, NALTREXONE, PREDNISONE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, ALBUTEROL SULFATE, ALBUTEROL, OMALIZUMAB, |
||||
| 30 | 25140868 |
CN |
87 | 1 |
Renal impairment, Leukocytosis, Haemolytic anaemia, Haematuria, Dyspnoea, |
||||
| 31 | 25140985 |
US |
1 | |
Autoimmune thyroiditis, Multiple sclerosis, Brain fog, Fatigue, Headache, Musculoskeletal stiffness, Dyspnoea, Heart rate increased, Insomnia, |
||||
OFATUMUMAB, OFATUMUMAB, |
||||
| 32 | 25141050 |
CA |
47 | 2 |
Cardiac failure congestive, Drug hypersensitivity, Nausea, Malaise, Drug ineffective, Diarrhoea, Abdominal discomfort, Abdominal pain upper, Arthralgia, Cough, Rash, Headache, Off label use, Product use issue, Hepatic enzyme increased, Liver disorder, Pain, Cardiac failure, Hypersensitivity, Dyspnoea, Gastrointestinal disorder, Hepatic steatosis, Hypertension, Therapeutic product effect decreased, Contraindicated product administered, |
||||
RABEPRAZOLE SODIUM, RABEPRAZOLE, RANITIDINE, COLCHICINE, PATIROMER, CELECOXIB, CEPHALEXIN, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, LEFLUNOMIDE, CLINDAMYCIN PHOSPHATE, CLINDAMYCIN, ENALAPRIL, ETANERCEPT, ALENDRONATE SODIUM, HYDRALAZINE HYDROCHLORIDE, HYDROCHLOROTHIAZIDE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, LOSARTAN, METHOTREXATE, METHOTREXATE SODIUM, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, MOXIFLOXACIN HYDROCHLORIDE, ABATACEPT, PENICILLIN G, HYDROXYCHLOROQUINE SULFATE, ISONIAZID, TOFACITINIB, RITUXIMAB, ADALIMUMAB, HYDROXYCHLOROQUINE SULFATE, ALENDRONATE SODIUM, CLARITHROMYCIN, HYDROXYCHLOROQUINE SULFATE, LEFLUNOMIDE, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, IRON SUCROSE, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, PERINDOPRIL ERBUMINE, PREDNISONE, ATENOLOL, LEVOTHYROXINE, |
||||
| 33 | 25141308 |
US |
||
Respiration abnormal, Spinal fracture, Nephrolithiasis, Multiple allergies, Musculoskeletal stiffness, Dyspnoea, Chest discomfort, Product use in unapproved indication, Product dose omission issue, |
||||
MEPOLIZUMAB, |
||||
| 34 | 25141432 |
CA |
64 | 1 |
Colitis ulcerative, Dyspnoea, Abdominal pain, Off label use, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, CHOLESTYRAMINE, |
||||
| 35 | 25141447 |
US |
70 | 1 |
Dyspnoea, Respiratory tract congestion, Condition aggravated, |
||||
DUPILUMAB, ENSIFENTRINE, |
||||
| 36 | 25141583 |
US |
18 | 2 |
Oxygen saturation decreased, Wheezing, Dyspnoea, Asthma, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, MONTELUKAST SODIUM, ALBUTEROL SULFATE, ALBUTEROL, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, |
||||
| 37 | 25141604 |
US |
1 | |
Dyspnoea, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 38 | 25141765 |
AE |
70 | 1 |
Skin reaction, Dyspnoea, |
||||
DONANEMAB-AZBT, DONANEMAB-AZBT, |
||||
| 39 | 25141766 |
PT |
55 | 2 |
Feeling abnormal, Hyperhidrosis, Flushing, Dyspnoea, |
||||
CETUXIMAB, |
||||
| 40 | 25141842 |
US |
76 | 1 |
Dyspnoea, |
||||
BOSUTINIB, |
||||
| 41 | 25141877 |
IT |
45 | 2 |
Urticaria, Laryngeal oedema, Dyspnoea, |
||||
AMOXICILLIN AND CLAVULANATE POTASSIUM, |
||||
| 42 | 25142041 |
US |
88 | |
Dyspnoea, Drug dose omission by device, Product use in unapproved indication, Wrong technique in product usage process, Device malfunction, |
||||
ALBUTEROL SULFATE, |
||||
| 43 | 25142098 |
IN |
54 | 1 |
Dyspnoea, Pulmonary oedema, Gait inability, |
||||
FAM-TRASTUZUMAB DERUXTECAN-NXKI, |
||||
| 44 | 25142102 |
CO |
70 | 2 |
Diaphragmatic paralysis, Diaphragmalgia, Dyspnoea, Muscle contracture, Muscle spasms, |
||||
DENOSUMAB, |
||||
| 45 | 25142143 |
US |
76 | 1 |
Dyspnoea, Malaise, Diarrhoea, Nausea, Off label use, |
||||
BOSUTINIB, BOSUTINIB, |
||||
| 46 | 25142191 |
US |
2 | |
Brow ptosis, Off label use, Dyspnoea, Tachycardia, Vertigo, Hypoaesthesia oral, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 47 | 25142221 |
US |
18 | 2 |
Rash, Dizziness, Dyspnoea, Hypotension, |
||||
IRON SUCROSE, METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA, |
||||
| 48 | 25142299 |
US |
2 | |
Dizziness, Unevaluable event, Dyspnoea, Muscular weakness, Diplopia, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 49 | 25142369 |
US |
50 | 2 |
Asthenia, Dyspnoea, Tachycardia, Postural orthostatic tachycardia syndrome, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 50 | 25142539 |
CA |
27 | 1 |
Dyspnoea, Product packaging confusion, Wrong dose, Throat tightness, Swelling face, Sinus congestion, Flushing, |
||||
SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, CAT HAIR, PHENOL, |
||||
| 51 | 25142576 |
CA |
40 | 2 |
Liver injury, Hepatitis, Lower respiratory tract infection, Pneumonia, Pericarditis, Pemphigus, Finger deformity, Hand deformity, Coeliac disease, Psoriatic arthropathy, Rheumatic fever, Systemic lupus erythematosus, Type 2 diabetes mellitus, Drug-induced liver injury, Abdominal discomfort, Abdominal distension, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Blood cholesterol increased, C-reactive protein increased, Condition aggravated, Confusional state, Drug hypersensitivity, Dyspepsia, Dyspnoea, Fatigue, Folliculitis, Gait inability, Gastrointestinal disorder, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Grip strength decreased, Headache, Helicobacter infection, Hepatic enzyme increased, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Inflammation, Infusion related reaction, Injection site reaction, Injury, Insomnia, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver function test increased, Lung disorder, Malaise, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Muscular weakness, Musculoskeletal pain, Musculoskeletal stiffness, Nail disorder, Nasopharyngitis, Nausea, Neck pain, Night sweats, Onychomadesis, Osteoarthritis, Pain, Pain in extremity, Paraesthesia, Peripheral swelling, Peripheral venous disease, Rash, Sleep disorder, Stomatitis, Swelling, Synovitis, Taste disorder, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Drug intolerance, Wound infection, Product label confusion, Exposure during pregnancy, Maternal exposure during pregnancy, Off label use, Product quality issue, |
||||
MIRABEGRON, MIRABEGRON, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN AND CODEINE, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ERENUMAB-AOOE, ERENUMAB-AOOE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, APREMILAST, APREMILAST, APREMILAST, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ATOMOXETINE, ATOMOXETINE, AZATHIOPRINE SODIUM, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CANDESARTAN, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ERGOCALCIFEROL, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, GOLD, GOLIMUMAB, GOLIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE BUTYRATE, HYDROCORTISONE BUTYRATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, INFLIXIMAB, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, SARILUMAB, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, MINOCYCLINE, MINOCYCLINE, MINOCYCLINE HYDROCHLORIDE, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NICOTINAMIDE, MEPOLIZUMAB, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, OXYCODONE, APREMILAST, PHENYLEPHRINE HYDROCHLORIDE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, RAMIPRIL, RAMIPRIL, RAMIPRIL, RANITIDINE, RANITIDINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, SULFASALAZINE, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, THIAMINE HYDROCHLORIDE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TRAMADOL HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, VITAMIN A, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, NAPROXEN, NAPROXEN SODIUM, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 52 | 25142654 |
US |
1 | |
Dyspnoea, |
||||
TREPROSTINIL, MACITENTAN, |
||||
| 53 | 25142745 |
PK |
50 | 1 |
Cardiac disorder, Alanine aminotransferase increased, Aspartate aminotransferase increased, Platelet count decreased, Neutrophil count increased, Acarodermatitis, Dyspnoea, |
||||
LINEZOLID, PRETOMANID, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN, |
||||
| 54 | 25142766 |
US |
35 | 1 |
Sleep disorder, Dyspnoea, |
||||
CARVEDILOL, SACUBITRIL AND VALSARTAN, FUROSEMIDE, |
||||
| 55 | 25145423 |
62 | 1 | |
Dyspnoea, |
||||
APREMILAST, |
||||
| 56 | 25146649 |
80 | 1 | |
Eosinophil count increased, Dyspnoea, Oxygen saturation decreased, Fatigue, |
||||
DAPTOMYCIN, |
||||
| 57 | 25138121 |
US |
||
Dyspnoea, Device use issue, Off label use, Product dose omission issue, |
||||
| 58 | 25138204 |
US |
||
Oropharyngeal pain, Headache, Stomatitis, Dyspnoea, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 59 | 25138245 |
US |
16 | |
Dyspnoea, Wrong technique in product usage process, Drug dose omission by device, |
||||
ALBUTEROL SULFATE, |
||||
| 60 | 25138288 |
US |
57 | 1 |
Dyspnoea, Middle insomnia, |
||||
DUPILUMAB, |
||||
| 61 | 25138493 |
US |
2 | |
Pulmonary oedema, Dyspnoea, Sinus headache, Emphysema, |
||||
DUPILUMAB, |
||||
| 62 | 25138501 |
US |
16 | 1 |
Asthma, Cough, Dyspnoea, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 63 | 25138504 |
US |
69 | 1 |
Dyspnoea, Product dose omission issue, |
||||
MEPOLIZUMAB, |
||||
| 64 | 25138591 |
US |
2 | |
Condition aggravated, Fracture, Dyspnoea, Chest pain, Urinary tract infection, Cardiac disorder, Hip fracture, Upper limb fracture, Loss of personal independence in daily activities, Pain in extremity, Muscle spasms, Sternal fracture, Intentional dose omission, Fatigue, Constipation, Sleep disorder, Abdominal pain upper, Back pain, Product use in unapproved indication, Product dose omission in error, |
||||
ABALOPARATIDE, DILTIAZEM HYDROCHLORIDE, OXYCODONE, TORSEMIDE, ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR, SACUBITRIL AND VALSARTAN, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, PANCRELIPASE, |
||||
| 65 | 25137199 |
JP |
60 | 2 |
Haemoptysis, Cough, Abdominal discomfort, Diarrhoea, Decreased appetite, Vomiting, Gastroenteritis, Nausea, Headache, Palpitations, Dyspnoea, Rhinorrhoea, Nasal congestion, Productive cough, Hypogeusia, Hyposmia, Coronavirus infection, Chest pain, Blood urea increased, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, SELEXIPAG, SELEXIPAG, MACITENTAN, RIOCIGUAT, DAPAGLIFLOZIN, TOLVAPTAN, |
||||
| 66 | 25137285 |
GB |
74 | 1 |
Influenza, Dyspnoea, |
||||
METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 67 | 25137296 |
US |
62 | 1 |
Pneumonia, Dyspnoea, |
||||
TREPROSTINIL, TREPROSTINIL, FUROSEMIDE, FOLIC ACID, LOSARTAN POTASSIUM, LOSARTAN, AMLODIPINE BESYLATE, MAGNESIUM, GABAPENTIN, SILDENAFIL CITRATE, SILDENAFIL, ALLOPURINOL, FLUTICASONE PROPIONATE, GLIPIZIDE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, OXYGEN, 0XYGEN, BUSPIRONE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 68 | 25137333 |
US |
24 | 1 |
Dyspnoea, Dysphagia, Therapeutic response decreased, |
||||
DUPILUMAB, |
||||
| 69 | 25137357 |
US |
71 | 1 |
Dyspnoea, |
||||
LENALIDOMIDE, |
||||
| 70 | 25137366 |
US |
29 | 2 |
Asthma, Cough, Dyspnoea, Wheezing, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 71 | 25137394 |
AU |
51 | 1 |
Dyspnoea, Chest pain, Coma scale abnormal, Diarrhoea, Disease progression, Microsporidia infection, Pneumocystis jirovecii infection, Therapeutic product effect incomplete, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, NITAZOXANIDE, ALLOPURINOL, AMLODIPINE, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, CANDESARTAN CILEXETIL, CARVEDILOL, CEFTRIAXONE, CEFTRIAXONE SODIUM, CLINDAMYCIN PHOSPHATE, CLINDAMYCIN, FUROSEMIDE, HYDRALAZINE HYDROCHLORIDE, PRAVASTATIN SODIUM, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, VORICONAZOLE, INSULIN ASPART, SEMAGLUTIDE, EVEROLIMUS, EVEROLIMUS TABLETS, NICOTINAMIDE, |
||||
| 72 | 25137438 |
SE |
46 | 2 |
Intraductal proliferative breast lesion, Dizziness, Postural orthostatic tachycardia syndrome, Dyspnoea, Amnesia, Tachycardia, Coronary artery disease, Visual impairment, Cognitive disorder, Dysphagia, Autonomic nervous system imbalance, |
||||
PACLITAXEL, |
||||
| 73 | 25137564 |
IT |
64 | 2 |
Dyspnoea, Feeling hot, |
||||
PACLITAXEL, |
||||
| 74 | 25137589 |
US |
56 | 2 |
Loss of personal independence in daily activities, Dyspnoea, |
||||
DUPILUMAB, |
||||
| 75 | 25137625 |
DE |
70 | 2 |
Metal poisoning, Inflammation, Dyspnoea, Swelling, Sleep disorder, Mineral metabolism disorder, Eating disorder, Blood pressure increased, Muscle atrophy, Scoliosis, Musculoskeletal stiffness, Muscle spasms, Pain, Chills, Pyrexia, Drug intolerance, |
||||
IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, DUPILUMAB, MAGNESIUM, CALCIUM, |
||||
| 76 | 25137672 |
US |
16 | 1 |
Completed suicide, Nausea, Vomiting, Dyspnoea, Cardiac arrest, Cardiac failure acute, Hypertrophic cardiomyopathy, Intentional overdose, Toxicity to various agents, |
||||
FLECAINIDE ACETATE TABLET, FLECAINIDE ACETATE, CAFFEINE, NALOXONE, |
||||
| 77 | 25137691 |
GB |
88 | 2 |
Hepatitis, Acute kidney injury, Hepatic cirrhosis, Hepatotoxicity, Nausea, Decreased appetite, Dyspnoea, Dyspepsia, Abdominal distension, Carbohydrate antigen 125 increased, Condition aggravated, |
||||
METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE, OXYCODONE, WATER, ACONITUM NAP, ARSENICUM ALB, BORAX, CALC PHOS, GELSENIUM, LYCOPODIUM, PHOSPHORICUM AC, PICRICUM AC, PLUMB MET, SOLIDAGO, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BECLOMETHASONE DIPROPIONATE, TEMAZEPAM, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, LOSARTAN, ISOSORBIDE MONONITRATE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, NITROGLYCERIN, METHYLPREDNISOLONE ACETATE, CLOTRIMAZOLE, DRS. CLOTRIMAZOLE, FAMILY WELLNESS CLOTRIMAZOLE, CLOTRIMAZOLE TOPICAL, CHLORPHENIRAMINE MALEATE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE, FUROSEMIDE, |
||||
| 78 | 25137693 |
PL |
67 | 1 |
Right ventricular failure, Thrombosis, Pulmonary embolism, Asthenia, Fatigue, Anxiety, Dyspnoea, |
||||
PEMETREXED, PEMETREXED DISODIUM, PEMETREXED, PEMETREXED DISODIUM, CISPLATIN, CISPLATIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 79 | 25137725 |
FR |
53 | 2 |
Feeling abnormal, Fatigue, Retinal vein occlusion, Anaemia, Road traffic accident, Fall, Craniocerebral injury, Vertigo, Cervical vertebral fracture, Back disorder, Hand dermatitis, Deafness, Dyspnoea, Dizziness, Chest pain, Inappropriate schedule of product administration, Mouth ulceration, Influenza, Eczema, Fear of falling, Drug intolerance, Tachycardia, Pain in extremity, Fear, Polyuria, Drug ineffective, Dry mouth, Lip injury, Serum ferritin decreased, |
||||
SPIRONOLACTONE, |
||||
| 80 | 25137787 |
AU |
51 | 1 |
Chest pain, Pneumocystis jirovecii infection, Coma scale abnormal, Diarrhoea, Disease progression, Dyspnoea, Microsporidia infection, Therapeutic product effect incomplete, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, INSULIN ASPART, NITAZOXANIDE, SEMAGLUTIDE, ALLOPURINOL, AMLODIPINE, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, CANDESARTAN CILEXETIL, CARVEDILOL, CEFTRIAXONE SODIUM, CLINDAMYCIN PHOSPHATE, CLINDAMYCIN, EVEROLIMUS, EVEROLIMUS TABLETS, FUROSEMIDE, HYDRALAZINE HYDROCHLORIDE, NICOTINAMIDE, PRAVASTATIN SODIUM, VORICONAZOLE, |
||||
| 81 | 25137793 |
US |
67 | 1 |
Dyspnoea, Wrong technique in device usage process, Wrong technique in product usage process, Product complaint, |
||||
ALBUTEROL SULFATE, |
||||
| 82 | 25137827 |
DE |
73 | 2 |
Dyspnoea, Product prescribing issue, Inflammation, Pyrexia, |
||||
TOBRAMYCIN SULFATE, TIOTROPIUM BROMIDE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, ERGOCALCIFEROL, ACYCLOVIR, OBINUTUZUMAB, |
||||
| 83 | 25137845 |
US |
68 | |
Product use issue, Gait disturbance, Dyspnoea, Device use issue, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 84 | 25137850 |
AU |
51 | 1 |
Diarrhoea, Pneumocystis jirovecii infection, Chest pain, Coma scale abnormal, Disease progression, Dyspnoea, Microsporidia infection, Therapeutic product effect incomplete, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, INSULIN ASPART, NITAZOXANIDE, ALLOPURINOL, AMLODIPINE BESYLATE, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, CANDESARTAN CILEXETIL, CARVEDILOL, CEFTRIAXONE SODIUM, CLINDAMYCIN HYDROCHLORIDE, EVEROLIMUS, EVEROLIMUS TABLETS, FUROSEMIDE, HYDRALAZINE HYDROCHLORIDE, NICOTINAMIDE, PRAVASTATIN SODIUM, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, VORICONAZOLE, SEMAGLUTIDE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, |
||||
| 85 | 25137894 |
US |
69 | 2 |
Dyspnoea, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, FOLIC ACID, LISINOPRIL, ALBUTEROL SULFATE, METHOTREXATE, METHOTREXATE SODIUM, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, OXYGEN, 0XYGEN, PREDNISONE, MECLIZINE HYDROCHLORIDE, MECLIZINE HCL, MECLIZINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 86 | 25137902 |
PL |
50 | 2 |
Vision blurred, Dyspnoea, Paraesthesia, Nausea, Ear discomfort, Asthenia, Speech disorder, Off label use, |
||||
BOTULINUM TOXIN TYPE A, BOTULINUM TOXIN TYPE A, BOTULINUM TOXIN TYPE A, BOTULINUM TOXIN TYPE A, |
||||
| 87 | 25137925 |
CA |
40 | 2 |
Pneumonia, Off label use, Pregnancy, Dyspnoea, Bronchitis, Gastroenteritis, COVID-19, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, MESALAMINE, |
||||
| 88 | 25137932 |
US |
84 | 2 |
COVID-19 pneumonia, Productive cough, Sputum discoloured, Throat irritation, Dyspnoea, Dyspnoea exertional, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, APIXABAN, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, METOLAZONE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, SUCRALFATE, SUCRALFATE ORAL SUSPENSION, SUCRALFATE ORAL, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, OXYGEN, 0XYGEN, HYOSCYAMINE SULFATE, FERROUS SULFATE, LORATADINE, LORATADINE ORAL, TORSEMIDE, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, ESCITALOPRAM OXALATE, ESCITALOPRAM, |
||||
| 89 | 25137960 |
US |
2 | |
Dyspnoea, Chills, Tremor, Hypoaesthesia, Heart rate increased, Dry mouth, Myalgia, Oropharyngeal pain, Intentional underdose, Drug ineffective, |
||||
FLUTICASONE PROPIONATE AND SALMETEROL, FLUTICASONE PROPIONATE AND SALMETEROL, |
||||
| 90 | 25137966 |
US |
81 | 2 |
Dyspnoea, Dizziness, Headache, Vision blurred, Gait disturbance, |
||||
EMPAGLIFLOZIN, MELATONIN, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, APIXABAN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, SILDENAFIL CITRATE, SILDENAFIL, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, ALBUTEROL SULFATE, ALLOPURINOL, BUMETANIDE, OXYGEN, 0XYGEN, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LIOTHYRONINE SODIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, DAPAGLIFLOZIN, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, SODIUM BICARBONATE, SODIUM BICARBONATE INJECTION,, METRONIDAZOLE, METRONIDAZOLE TOPICAL, |
||||
| 91 | 25138005 |
US |
63 | 2 |
Chest discomfort, Dyspnoea, Asthenia, Condition aggravated, |
||||
DUPILUMAB, |
||||
| 92 | 25138013 |
DE |
55 | 1 |
Anaphylactic shock, Dyspnoea, Fear of death, Hypokinesia, Anxiety, Oxygen saturation decreased, Chills, Asthenia, Headache, |
||||
| 93 | 25140760 |
73 | 1 | |
Dyspnoea, Headache, Vomiting, Hypertension, |
||||
EVEROLIMUS, EVEROLIMUS TABLETS, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FUROSEMIDE, GABAPENTIN, PSYLLIUM HUSK, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, |
||||
| 94 | 25141429 |
41 | 2 | |
Flushing, Tinnitus, Anxiety, Palpitations, Dyspnoea, Confusional state, Disorientation, Anal incontinence, Urinary incontinence, Vomiting, Hypoaesthesia, Paraesthesia, Neck pain, Chills, Dystonia, |
||||
GLATIRAMER ACETATE, |
||||
| 95 | 25132126 |
20 | 2 | |
Tearfulness, Fatigue, Irritability, Urticaria, Dyspnoea, |
||||
SOLRIAMFETOL, |
||||
| 96 | 25132201 |
AU |
||
Acute hepatic failure, Dyspnoea, Anxiety, Thinking abnormal, Coordination abnormal, Dizziness, Constipation, Dysuria, Dysphagia, Prescribed overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
| 97 | 25132206 |
CA |
72 | 2 |
Blood pressure systolic increased, Kyphosis, Dyspnoea exertional, Feeling abnormal, Forced vital capacity decreased, FEV1/FVC ratio decreased, Inflammation, Pain in extremity, Nasopharyngitis, Obstructive airways disorder, Musculoskeletal chest pain, Headache, Inappropriate schedule of product administration, Overdose, Chronic spontaneous urticaria, Cough, Asthma, Dizziness, Dyspnoea, Weight decreased, Fatigue, Rash, |
||||
CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ALBUTEROL SULFATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CALCIUM, EZETIMIBE, EZETIMIBE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LEVOTHYROXINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, HYDROCHLOROTHIAZIDE, LEVOTHYROXINE SODIUM, ROSUVASTATIN CALCIUM, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, |
||||
| 98 | 25132222 |
CO |
65 | 2 |
Haemoglobin decreased, Blood creatinine increased, Dehydration, Diarrhoea, Vomiting, Abdominal pain upper, Balance disorder, Tremor, Tongue dry, Dyspnoea, Agitation, Nausea, Platelet count decreased, Asthenia, |
||||
ABEMACICLIB, |
||||
| 99 | 25132237 |
RU |
63 | 2 |
Malaise, Asthenia, Dyspnoea, Body temperature increased, Dyspnoea exertional, Pyrexia, Interstitial lung disease, Pleural effusion, Cardiomegaly, Renal cyst, Hepatic cyst, Cough, |
||||
| 100 | 25132245 |
US |
2 | |
Pneumonia, Malaise, Dyspnoea, Chest pain, Bronchitis, |
||||
SECUKINUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28